DCN and pancreatic neoplasm: Similarly, a neurotensin peptide-conjugated polyethylene glycol (PEG-NT)-coated OAd was engineered to express both decorin (DCN) and a soluble Wnt decoy peptide sLRP6E1E2 (oAd/DCN/LRP-PEG-NT) specifically targeting pancreatic cancer [62].